Novel cardiovascular risk factors and macrovascular and microvascular complications of diabetes

P Theuma1, V A Fonseca

  • 1Tulane Diabetes Program, Department of Medicine, Section of Endocrinology, Tulane University Medical Center, SL-53, 1430 Tulane Avenue, New Orleans, Louisiana 70112-2699, USA. ptheuma@tulane.edu

Current Drug Targets
|July 18, 2003
PubMed

Insights

Managing diabetes mellitus complications requires addressing non-traditional risk factors beyond traditional ones. Early intervention for metabolic syndrome may prevent type 2 diabetes and its vascular issues.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Metabolic Diseases

Background:

  • Diabetes mellitus continues to cause significant morbidity and mortality, even with management of traditional risk factors.
  • Emerging evidence suggests non-traditional factors play a crucial role in the pathophysiology of diabetic macrovascular and microvascular complications.
  • Metabolic syndrome often precedes type 2 diabetes, indicating a potential window for early intervention.

Purpose of the Study:

  • To review current knowledge on non-traditional risk factors for diabetes complications.
  • To discuss potential therapies targeting these non-traditional risk factors.
  • To explore the role of metabolic syndrome in delaying diabetes onset and complications.

Main Methods:

  • Literature review of recent data on non-traditional risk factors.
  • Discussion of pathophysiological mechanisms including endothelial dysfunction, inflammation, and impaired fibrinolysis.
  • Exploration of the potential significance of infection and hyperhomocysteinemia.

Main Results:

  • Endothelial dysfunction, subclinical inflammation, and impaired fibrinolysis are implicated in the progression of both macrovascular and microvascular complications.
  • The roles of infection and hyperhomocysteinemia in diabetes progression warrant further investigation.
  • Early treatment of metabolic syndrome may delay the onset of type 2 diabetes and its associated complications.

Conclusions:

  • Addressing non-traditional risk factors is essential for improving outcomes in diabetes mellitus.
  • Targeting metabolic syndrome and associated factors like endothelial dysfunction and inflammation may offer new therapeutic strategies.
  • Further research is needed to clarify the roles of infection and hyperhomocysteinemia in diabetes complications.

Related Concept Videos

Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...